Evidence map›Paper›PMID 27733552›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis.

Lance W Peterson, Naomi H Philip, Christopher P Dillon, John Bertin, Peter J Gough, Douglas R Green, Igor E Brodsky

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Anti-infective compounds forSustainable microbiology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Death by TNF: a road to inflammation.Nature reviews. Immunology · 2023
    Review
  14. A TNF-IL-1 circuit controlsbioRxiv : the preprint server for biology · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Heightened Virulence ofInfection and immunity · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lance W PetersonDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104.ORCID 0000-0003-2458-6678
Naomi H PhilipDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104.
Christopher P DillonDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105; and.ORCID 0000-0002-9458-0266
John BertinPattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19422.
Peter J GoughPattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19422.ORCID 0000-0002-5110-9300
Douglas R GreenDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105; and.
Igor E BrodskyDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104; ibrodsky@vet.upenn.edu.ORCID 0000-0001-7970-872X
University of Pennsylvania · USGlaxoSmithKline (United States) · USSt. Jude Children's Research Hospital · US

Funding

Survival Function of the Fadd-Caspase-8-Flip ComplexR01AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI GREEN, DOUGLAS R. · 1999 to 2016
$6.3M
TRAINING PROGRAM/RHEUMATIC DISEASEST32AR007442 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI BEHRENS, EDWARD M, MERKEL, PETER A · 1986 to 2018
$5.8M
Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT ExtensionR37AI044828 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Douglas R. Green · 2017 to 2026
$4.5M
Modulation of Inflammasome Activation by YersiniaR01AI103062 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2013 to 2016
$1.7M
Dissecting the mechanism of RIPK1 kinase-dependent cell death in control of Yersinia infectionR21AI125924 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2016 to 2017
$459k
Harnessing inflammasome activation to enhance efficacy of Salmonella vaccinesR21AI117365 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2015 to 2016
$449k
Role of Caspase-8 in Yersinia virulence and host defenseR21AI109267 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2014 to 2015
$440k
NIAID NIH HHS R01 AI044828NIAID NIH HHS R01 AI103062NIAID NIH HHS R21 AI109267NIAID NIH HHS R21 AI117365NIAID NIH HHS R21 AI125924NIAID NIH HHS R37 AI044828NIAMS NIH HHS T32 AR007442
6 · The paper itself

Abstract

Innate immune responses that are crucial for control of infection are often targeted by microbial pathogens. Blockade of NF-κB and MAPK signaling by the Yersinia virulence factor YopJ inhibits cytokine production by innate immune cells but also triggers cell death. This cell death requires RIPK1 kinase activity and caspase-8, which are engaged by TLR4 and the adaptor protein TRIF. Nevertheless, TLR4- and TRIF-deficient cells undergo significant apoptosis, implicating TLR4/TRIF-independent pathways in the death of Yersinia-infected cells. In this article, we report a key role for TNF/TNFR1 in Yersinia-induced cell death of murine macrophages, which occurs despite the blockade of NF-κB and MAPK signaling imposed by Yersinia on infected cells. Intriguingly, direct analysis of YopJ injection revealed a heterogeneous population of injection-high and injection-low cells, and demonstrated that TNF expression came from the injection-low population. Moreover, TNF production by this subpopulation was necessary for maximal apoptosis in the population of highly injected cells, and TNFR-deficient mice displayed enhanced susceptibility to Yersinia infection. These data demonstrate an important role for collaboration between TNF and pattern recognition receptor signals in promoting maximal apoptosis during bacterial infection, and demonstrate that heterogeneity in virulence factor injection and cellular responses play an important role in promoting anti-Yersinia immune defense.

Indexed as

ApoptosisAdaptor Proteins, Vesicular TransportAnimalsBacterial ProteinsCaspase 1Cell DeathImmunity, InnateL-Lactate DehydrogenaseMacrophagesMicePlasmidsSignal TransductionToll-Like Receptor 4Tumor Necrosis FactorsYersinia InfectionsYersinia pseudotuberculosisAdaptor Proteins, Vesicular TransportBacterial ProteinsCaspase 1L-Lactate DehydrogenaseTicam1 protein, mouseToll-Like Receptor 4Tumor Necrosis FactorsYopP protein, Yersinia

Identifiers

PMID27733552
PMCPMC5123756
OpenAlexW2538873941

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.